Refractory Large B-cell Lymphoma
4 clinical trials · Condition
◉ Watch Refractory Large B-cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Outpatient Epcoritamab in Large B-cell Lymphoma (NCT06811272) | Massachusetts General Hospital | 2025-06-05 |
| Study of Safety and Efficacy of TC011 in the Relapsed/Refractory Large B Cell Non-Hodgkin Lymphoma Patients (NCT07473167) | TICAROS Co., Ltd. | 2023-08-03 |
| Study of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma and B-cell Acute Lymphoblastic Leukemia Patients (NCT04836507) | Curocell Inc. | 2021-03-02 |
| Safety and Efficacy of Axicabtagene Ciloleucel in Combination With Rituximab in Participants With Refractory Large B-Cell Lymphoma (NCT04002401) | Kite, A Gilead Company | 2019-11-05 |
Track Refractory Large B-cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.